Abstract
The inhibitors of the enzymes tyrosine kinase (ITKs), also known by "tinibs", have been used as the most modern and effective tools in the treatment of several types of cancer. This article is a compilation of a huge series of tyrosine kinase inhibitors, recently approved or under clinical trials, containing in each of them information such as: The first chemical synthesis, the mechanism of action against cancer, clinical trials stage and price in the market.
Author supplied keywords
Cite
CITATION STYLE
Costa, D. C. S., Forezi, L. S. M., Cardoso, M. F. C., Ribeiro, R. C. B., Pinto, A. C., Ferreira, V. F., & Da Silva, F. C. (2017). A Compendium of tyrosine-kinase inhibitors: Powerful and efficient drugs against cancer. Revista Virtual de Quimica, 9(3), 974–1064. https://doi.org/10.21577/1984-6835.20170063
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.